-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
2019 IASLC Latin American Conference
-
Highlights From the 2019 IASLC Latin American Conference in Lung Cancer
By Luis E. Raez, MD, FACP, FCCP Posted: December 11, 2019 The 8th IASLC Latin American Conference in Lung Cancer (LALCA) was held in Mexico City, Mexico, from October 18 to 20, 2019. The LALCA is the main event of the IASLC Latin American Group (LATAM), which has close to 500 members in almost 20…
View ILCN Archives
Provider Resources
Popular Articles